{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:12:35Z","timestamp":1785496355307,"version":"3.56.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2013R1A2A2A01068077"],"award-info":[{"award-number":["2013R1A2A2A01068077"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Soonchunhyang Univ."}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.rmed.2016.11.020","type":"journal-article","created":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T02:15:15Z","timestamp":1479953715000},"page":"71-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Association of interleukin-25 levels with development of aspirin induced respiratory diseases"],"prefix":"10.1016","volume":"123","author":[{"given":"Jong-Uk","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hun Soo","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Jeong","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hye","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Sook","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Sung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hun Gyu","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choon-Sik","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.rmed.2016.11.020_bib1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4168\/aair.2016.8.4.298","article-title":"Update on the management of aspirin-exacerbated respiratory disease","volume":"8","author":"Buchheit","year":"2016","journal-title":"Allergy, Asthma & Immunol. Res."},{"issue":"3","key":"10.1016\/j.rmed.2016.11.020_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1081-1206(10)62221-1","article-title":"Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes, Annals of allergy, asthma & immunology : official publication of the American College of Allergy","volume":"87","author":"Stevenson","year":"2001","journal-title":"Asthma, & Immunol."},{"issue":"19","key":"10.1016\/j.rmed.2016.11.020_bib3","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJMoa013508","article-title":"Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis","volume":"347","author":"Sousa","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"12","key":"10.1016\/j.rmed.2016.11.020_bib4","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1136\/thx.2008.101196","article-title":"Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma","volume":"63","author":"Gaber","year":"2008","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.rmed.2016.11.020_bib5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1067\/mai.2003.1387","article-title":"A\u00a0controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge","volume":"111","author":"Bochenek","year":"2003","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.rmed.2016.11.020_bib6","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1034\/j.1399-3003.2000.016003432.x","article-title":"Natural history of aspirin-induced asthma. AIANE investigators. European network on aspirin-induced asthma","volume":"16","author":"Szczeklik","year":"2000","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2016.11.020_bib7","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1378\/chest.128.5.3127","article-title":"Comparison of plasma eotaxin family level in aspirin-induced and aspirin-tolerant asthma patients","volume":"128","author":"Min","year":"2005","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.rmed.2016.11.020_bib8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2500\/ajr.2007.21.3066","article-title":"Exhaled inflammatory markers in aspirin-induced asthma syndrome","volume":"21","author":"Carpagnano","year":"2007","journal-title":"Am. J. Rhinology"},{"issue":"10","key":"10.1016\/j.rmed.2016.11.020_bib9","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.rmed.2010.04.017","article-title":"Mediators of inflammation in nasal lavage from aspirin intolerant patients after aspirin challenge","volume":"104","author":"Kupczyk","year":"2010","journal-title":"Respir. Med."},{"issue":"5","key":"10.1016\/j.rmed.2016.11.020_bib10","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1067\/mai.2003.1487","article-title":"Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management","volume":"111","author":"Szczeklik","year":"2003","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.rmed.2016.11.020_bib11","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jaci.2013.05.012","article-title":"IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction","volume":"132","author":"Barlow","year":"2013","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.rmed.2016.11.020_bib12","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.1206587110","article-title":"IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms","volume":"110","author":"Hung","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.rmed.2016.11.020_bib13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1600-065X.2008.00713.x","article-title":"Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites","volume":"226","author":"Saenz","year":"2008","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.rmed.2016.11.020_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1084\/jem.20062211","article-title":"Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells","volume":"204","author":"Allakhverdi","year":"2007","journal-title":"J.\u00a0Exp. Med."},{"issue":"1","key":"10.1016\/j.rmed.2016.11.020_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-7961-10-8","article-title":"IL-3 and TNFalpha increase Thymic Stromal Lymphopoietin Receptor (TSLPR) expression on eosinophils and enhance TSLP-stimulated degranulation","volume":"10","author":"Cook","year":"2012","journal-title":"Clin. Mol. Allergy CMA"},{"issue":"8","key":"10.1016\/j.rmed.2016.11.020_bib16","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nm.3281","article-title":"Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis","volume":"19","author":"Noti","year":"2013","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.rmed.2016.11.020_bib17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cyto.2013.06.272","article-title":"269 : TSLP driven expansion and activation of type 2 innate lymphoid cells is augmented by IL-25 and IL-33","volume":"63","author":"Vissinga","year":"2013","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.rmed.2016.11.020_bib18","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jaci.2008.10.022","article-title":"CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation","volume":"123","author":"Allakhverdi","year":"2009","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.rmed.2016.11.020_bib19","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4049\/jimmunol.179.4.2051","article-title":"Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells","volume":"179","author":"Allakhverdi","year":"2007","journal-title":"J.\u00a0Immunol. (Baltim. Md. 1950)"},{"issue":"4","key":"10.1016\/j.rmed.2016.11.020_bib20","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1084\/jem.20051615","article-title":"Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion","volume":"203","author":"Fallon","year":"2006","journal-title":"J.\u00a0Exp. Med."},{"issue":"4","key":"10.1016\/j.rmed.2016.11.020_bib21","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jaci.2013.10.056","article-title":"Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells","volume":"133","author":"Xue","year":"2014","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.rmed.2016.11.020_bib22","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1164\/rccm.201212-2227OC","article-title":"IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps","volume":"188","author":"Shaw","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2016.11.020_bib23","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jaci.2015.10.020","article-title":"Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease","volume":"137","author":"Buchheit","year":"2016","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.rmed.2016.11.020_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1084\/jem.193.2.255","article-title":"Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2","volume":"193","author":"Hirai","year":"2001","journal-title":"J.\u00a0Exp. Med."},{"issue":"2","key":"10.1016\/j.rmed.2016.11.020_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0014-5793(99)01251-X","article-title":"CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s)","volume":"459","author":"Nagata","year":"1999","journal-title":"FEBS Lett."},{"issue":"11","key":"10.1016\/j.rmed.2016.11.020_bib26","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ni.2104","article-title":"Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161","volume":"12","author":"Mjosberg","year":"2011","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.rmed.2016.11.020_bib27","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.4049\/jimmunol.1500905","article-title":"Aspirin-exacerbated respiratory disease involves a cysteinyl leukotriene-driven IL-33-mediated mast cell activation pathway","volume":"195","author":"Liu","year":"2015","journal-title":"J.\u00a0Immunol. (Baltim. Md. 1950)"},{"issue":"10","key":"10.1016\/j.rmed.2016.11.020_bib28","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1398-9995.2007.01409.x","article-title":"EAACI\/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity","volume":"62","author":"Nizankowska-Mogilnicka","year":"2007","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.rmed.2016.11.020_bib29","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4168\/aair.2011.3.4.256","article-title":"Diagnostic value of clinical parameters in the prediction of aspirin-exacerbated respiratory disease in asthma","volume":"3","author":"Chang","year":"2011","journal-title":"Allergy, Asthma & Immunol. Res."},{"issue":"1","key":"10.1016\/j.rmed.2016.11.020_bib30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pcrj.2005.10.004","article-title":"International primary care respiratory group (IPCRG) guidelines: diagnosis of respiratory diseases in primary care","volume":"15","author":"Levy","year":"2006","journal-title":"Prim. Care Respir. J. J. General Pract. Airw. Group"},{"issue":"2","key":"10.1016\/j.rmed.2016.11.020_bib31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2500\/ajra.2010.24.3446","article-title":"Treatment-recalcitrant chronic rhinosinusitis with polyps is associated with altered epithelial cell expression of interleukin-33","volume":"24","author":"Reh","year":"2010","journal-title":"Am. J. Rhinology Allergy"},{"issue":"8","key":"10.1016\/j.rmed.2016.11.020_bib32","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3109\/02770903.2014.921196","article-title":"IL-33 promotes airway remodeling and is a marker of asthma disease severity","volume":"51","author":"Guo","year":"2014","journal-title":"J.\u00a0Asthma Off. J. Assoc. Care Asthma"},{"issue":"5","key":"10.1016\/j.rmed.2016.11.020_bib33","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jaci.2009.12.977","article-title":"Profile of eicosanoid generation in aspirin-intolerant asthma and anaphylaxis assessed by new biomarkers","volume":"125","author":"Higashi","year":"2010","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"6","key":"10.1016\/j.rmed.2016.11.020_bib34","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S1074-7613(01)00243-6","article-title":"IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in\u00a0vivo","volume":"15","author":"Fort","year":"2001","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.rmed.2016.11.020_bib35","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1182\/blood-2002-09-2817","article-title":"Mast cells produce interleukin-25 upon Fc epsilon RI-mediated activation","volume":"101","author":"Ikeda","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.rmed.2016.11.020_bib36","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3389\/fimmu.2014.00569","article-title":"Mast cell mediators: their differential release and the secretory pathways involved","volume":"5","author":"Moon","year":"2014","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.rmed.2016.11.020_bib37","first-page":"e00","article-title":"Aspirin induces IL-4 production: augmented IL-4 production in aspirin-exacerbated respiratory disease","volume":"47","author":"Kong","year":"2015","journal-title":"Exp. Mol. Med."},{"issue":"3","key":"10.1016\/j.rmed.2016.11.020_bib38","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1034\/j.1399-3003.1999.14c21.x","article-title":"Inflammatory cell populations and cytokine mRNA expression in the nasal mucosa in aspirin-sensitive rhinitis","volume":"14","author":"Varga","year":"1999","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2016.11.020_bib39","first-page":"182090","article-title":"Interleukin-4 in the generation of the AERD phenotype: implications for molecular mechanisms driving therapeutic benefit of aspirin desensitization","volume":"2012","author":"Steinke","year":"2012","journal-title":"J.\u00a0Allergy"},{"issue":"5174","key":"10.1016\/j.rmed.2016.11.020_bib40","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","article-title":"Inhibition of NF-kappa B by sodium salicylate and aspirin","volume":"265","author":"Kopp","year":"1994","journal-title":"Sci. (New York, N.Y.)"},{"issue":"14","key":"10.1016\/j.rmed.2016.11.020_bib41","doi-asserted-by":"crossref","first-page":"8089","DOI":"10.1074\/jbc.271.14.8089","article-title":"Inhibition of tumor necrosis factor-induced p42\/p44 mitogen-activated protein kinase activation by sodium salicylate","volume":"271","author":"Schwenger","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"issue":"3","key":"10.1016\/j.rmed.2016.11.020_bib42","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.4049\/jimmunol.168.3.1428","article-title":"Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6","volume":"168","author":"Perez","year":"2002","journal-title":"J.\u00a0Immunol. (Baltim. Md. 1950)"},{"issue":"4","key":"10.1016\/j.rmed.2016.11.020_bib43","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jaci.2009.07.031","article-title":"Modulation by aspirin of nuclear phospho-signal transducer and activator of transcription 6 expression: possible role in therapeutic benefit associated with aspirin desensitization","volume":"124","author":"Steinke","year":"2009","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"issue":"12","key":"10.1016\/j.rmed.2016.11.020_bib44","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/FPC.0b013e3283402155","article-title":"Effect of single nucleotide polymorphisms within the interleukin-4 promoter on aspirin intolerance in asthmatics and interleukin-4 promoter activity","volume":"20","author":"Kim","year":"2010","journal-title":"Pharmacogenetics Genomics"},{"issue":"1","key":"10.1016\/j.rmed.2016.11.020_bib45","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/MCB.18.1.78","article-title":"Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IkappaB alpha phosphorylation and degradation","volume":"18","author":"Schwenger","year":"1998","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.rmed.2016.11.020_bib46","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1038\/emm.2015.96","article-title":"Aspirin induces IL-4 production: augmented IL-4 production in aspirin-exacerbated respiratory disease","volume":"48","author":"Kong","year":"2016","journal-title":"Exp. Mol. Med."},{"issue":"7","key":"10.1016\/j.rmed.2016.11.020_bib47","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1182\/blood.V92.7.2389","article-title":"Salicylates inhibit adhesion and transmigration of T lymphocytes by preventing integrin activation induced by contact with endothelial cells","volume":"92","author":"Gerli","year":"1998","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.rmed.2016.11.020_bib48","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.4049\/jimmunol.146.8.2553","article-title":"Aspirin-like drugs prime human T cells. Modulation of intracellular calcium concentrations","volume":"146","author":"Flescher","year":"1991","journal-title":"J.\u00a0Immunol. (Baltim. Md. 1950)"},{"issue":"1","key":"10.1016\/j.rmed.2016.11.020_bib49","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/(SICI)1097-4652(199904)179:1<109::AID-JCP13>3.0.CO;2-W","article-title":"Cell-type-specific activation of c-Jun N-terminal kinase by salicylates","volume":"179","author":"Schwenger","year":"1999","journal-title":"J.\u00a0Cell. Physiology"},{"issue":"2","key":"10.1016\/j.rmed.2016.11.020_bib50","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1124\/mol.65.2.470","article-title":"Aspirin-mediated COX-2 transcript stabilization via sustained p38 activation in human intestinal myofibroblasts","volume":"65","author":"Mifflin","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"11","key":"10.1016\/j.rmed.2016.11.020_bib51","doi-asserted-by":"crossref","first-page":"e13818","DOI":"10.1371\/journal.pone.0013818","article-title":"Genome-wide and follow-up studies identify CEP68 gene variants associated with risk of aspirin-intolerant asthma","volume":"5","author":"Kim","year":"2010","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.rmed.2016.11.020_bib52","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00439-012-1247-2","article-title":"Genome-wide association study of aspirin-exacerbated respiratory disease in a Korean population","volume":"132","author":"Park","year":"2013","journal-title":"Hum. Genet."},{"issue":"11","key":"10.1016\/j.rmed.2016.11.020_bib53","doi-asserted-by":"crossref","first-page":"e111887","DOI":"10.1371\/journal.pone.0111887","article-title":"Exonic variants associated with development of aspirin exacerbated respiratory diseases","volume":"9","author":"Shin","year":"2014","journal-title":"PloS One"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611116303171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611116303171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:36:21Z","timestamp":1760614581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611116303171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":53,"alternative-id":["S0954611116303171"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2016.11.020","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of interleukin-25 levels with development of aspirin induced respiratory diseases","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2016.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}